US Canada Trade Talks Put These Cross Border Stocks In Focus
Ongoing US-Canada trade talks have created a mix of relief and risk for cross-border trade stocks after a pause in tariffs. This article highlights three companies – Turning Point Brands (TPB), Uranium Energy (UEC), and Greenfire Resources (GFR) – whose performance could be significantly impacted by the evolving trade landscape, due to their direct exposure to cross-border consumer demand, energy supply chains, and oil sands operations, respectively. Investors are encouraged to monitor these stocks closely as trade negotiations progress.
US Canada Trade Talks Put These Cross Border Stocks In Focus
A recent pause in proposed U.S. tariffs on Canadian imports has brought cross-border trade stocks into focus, presenting both relief and risk. This article examines three companies—Turning Point Brands (TPB), Uranium Energy (UEC), and Greenfire Resources (GFR)—that could be significantly impacted by ongoing U.S.-Canada trade talks. It highlights their operations, market relevance, and financial health, suggesting these stocks warrant close monitoring as trade relations evolve.
Turning Point Brands (TPB) Lifts 2026 Guidance, Is The Stock Already Pricey?
Turning Point Brands (TPB) has raised its 2026 earnings guidance, driven by its Modern Oral products and the launch of FRE Labs. Despite this positive outlook, the stock has softened year-to-date, though it shows strong long-term shareholder returns. The article discusses whether TPB is undervalued at its current price of $85.30 compared to a fair value narrative of $130, driven by significant growth in the Modern Oral nicotine pouch segment, or if its P/E ratio of 38.4x suggests it's already priced for this growth.
Crown Advisors Management Inc. Acquires Shares of 15,000 Turning Point Brands, Inc. $TPB
Crown Advisors Management Inc. has acquired a new position of 15,000 shares in Turning Point Brands, Inc. (NYSE:TPB) during the second quarter, valued at approximately $1.27 million. This purchase gives Crown Advisors Management a 0.08% stake in the company, which has seen 96.12% of its stock owned by institutional investors. Turning Point Brands recently declared a quarterly dividend of $0.08 per share and holds a consensus "Moderate Buy" rating from analysts with a target price of $115.67.
Why Turning Point Brands (TPB) Is Up 6.8% After Raising 2026 Modern Oral Sales Guidance
Turning Point Brands (TPB) saw its stock rise by 6.8% after increasing its full-year 2026 Modern Oral sales guidance. Despite reporting higher sales but lower net income in Q2 2026, the company's updated outlook projects gross sales between US$330 million and US$350 million for its Modern Oral segment, highlighting its growing importance as a key growth catalyst. This comes even as the company completed a share repurchase program and faces continued earnings volatility due to spending and competition.
Price-Driven Insight from (TPB) for Rule-Based Strategy
This article provides a price-driven analysis for Turning Point Brands Inc. (NYSE: TPB), highlighting strong near and mid-term sentiment despite a weak long-term outlook. It details three AI-generated institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis and support/resistance levels. The analysis emphasizes an exceptional risk-reward setup targeting a significant gain with minimal risk.
Why Turning Point Brands (TPB) Is Up 6.8% After Raising 2026 Modern Oral Sales Guidance
Turning Point Brands (TPB) saw its stock rise by 6.8% after raising its full-year 2026 Modern Oral sales guidance. Despite reporting lower net income in Q2 2026, the company increased projected gross sales for its Modern Oral segment to US$330 million–US$350 million and net sales to US$260 million–US$270 million, highlighting the segment's growing importance and its central role in the company's investment narrative.
FRE Fans Help Choose Which Limited-Edition Flavors Return
Turning Point Brands (NYSE: TPB) has launched FRE Labs, a new flavor innovation platform for its FRE nicotine pouches. This initiative allows adult consumers to influence the brand's future portfolio by providing feedback on limited-edition flavors and voting on which ones should become permanent. The first release, part of the "Ice line," features fruit-forward flavors with a cooling menthol finish, starting with Blackberry Lemon Ice, and will be available exclusively online.
Why Turning Point Brands (TPB) Is Up 6.8% After Raising 2026 Modern Oral Sales Guidance
Turning Point Brands (TPB) saw its stock rise by 6.8% after increasing its full-year 2026 Modern Oral sales guidance, projecting gross sales between US$330 million and US$350 million. This guidance update highlights the increasing importance of the Modern Oral segment for the company's growth, despite a recent quarter showing higher sales but lower net income. The article emphasizes that the investment narrative for TPB is now heavily reliant on the expansion of its Modern Oral products, balanced against regulatory risks and competitive pressures.
BTIG Maintains Turning Point Brands(TPB.US) With Buy Rating, Raises Target Price to $116
BTIG has reiterated its Buy rating on Turning Point Brands (TPB.US) and increased its price target to $116. This indicates a positive outlook from the firm regarding the company's future performance and stock value.
Turning Point Brands (TPB) Stock Climbed, What Is Driving Attention Now?
Turning Point Brands (TPB) is gaining attention due to strong Q2 sales in its Modern Oral segment and raised full-year guidance for this category. Despite a year-to-date share price decline, the stock saw recent gains, with analysts valuing it at $130, suggesting it's undervalued. However, its high P/E ratio compared to the industry and potential risks from increased spending or regulatory changes in nicotine pouches warrant caution.
Turning Point Brands : TPB
This article provides an overview of Turning Point Brands (TPB), a consumer products company specializing in smoking accessories and tobacco products like Zig-Zag and Stoker’s. It highlights the company's market presence since 1988 and its current stock data. The piece also includes a recent article discussing why Universal Corp (UVV) stock is falling and if other tobacco stocks are experiencing similar declines.
TURNING POINT BRANDS INC : BTIG RAISES TARGET PRICE TO $116 FROM $103
BTIG has increased its target price for Turning Point Brands Inc. (TPB.N) to $116 from $103. This report, attributed to Reuters, was published on August 10, 2026, at 05:13, indicating an updated outlook from the analyst firm for the company's stock.
Turning Point Brands Q2 Earnings Call Highlights
Turning Point Brands reported a 23% increase in Q2 2026 consolidated net sales, reaching $143 million, primarily driven by its Modern Oral nicotine pouch business. Despite this growth, adjusted EBITDA declined by 50% to $15 million due to increased sales and marketing investments and softness in the Zig-Zag segment. The company raised its 2026 Modern Oral gross sales outlook and is investing in expanding its sales force and U.S. manufacturing capabilities.
TURNING POINT BRANDS INC : BTIG RAISES TARGET PRICE TO $116 FROM $103
BTIG has increased its target price for Turning Point Brands Inc (TPB.N) to $116, up from the previous $103. This indicates a more optimistic outlook by the analyst firm regarding the company's future stock performance.
Turning Point Brands (NYSE:TPB) Raised to Sell at Wall Street Zen
Wall Street Zen upgraded Turning Point Brands (NYSE:TPB) from a "strong sell" to a "sell" rating, despite the broader analyst consensus remaining a "Moderate Buy" with a $113.50 average price target. The company recently surpassed quarterly earnings and revenue expectations, reporting $0.76 EPS and $124.28 million in revenue. Institutional investors hold 96.12% of shares, though a company executive recently reduced their position by selling 4,000 shares.
Can Turning Point Brands Defend a "Dr. Pepper"‑Size Share After the FDA's Nicotine Pouch Decision?
Turning Point Brands (TPB) is heavily relying on its Fre and ALP nicotine pouch lines for growth, with over 40% of its sales now coming from this fast-growing sector. The upcoming earnings report will be crucial in determining if TPB can maintain its market share amidst increasing competition from larger tobacco companies. The article also highlights an investment opportunity signaled by The Motley Fool for a company 1/100th the size of Nvidia.
Can Turning Point Brands Defend a "Dr. Pepper"‑Size Share After the FDA's Nicotine Pouch Decision?
Turning Point Brands (TPB) is heavily relying on its nicotine pouch products, Fre and ALP lines, for growth, with over 40% of its sales now coming from this fast-growing segment. The article questions whether TPB can maintain its niche market share as larger tobacco companies enter the nicotine pouch market. Upcoming earnings reports are expected to shed light on the company's competitive future in this evolving landscape.
Is Turning Point Brands’ (TPB) Modern Oral Upgrade Outweighing Margin Squeeze in Its Growth Story?
Turning Point Brands (TPB) reported higher Q2 2026 sales but lower net income year-on-year, though it repurchased shares and maintained its dividend. The company raised its full-year 2026 Modern Oral sales guidance, making this segment central to its growth strategy despite potential regulatory and competitive risks. While Simply Wall St's analysis suggests a 50% upside to its current price, community estimates for fair value vary significantly, highlighting divergent opinions on the sustainability of this growth.
Turning Point Brands (TPB) Stock Rises As Nicotine Pouches Squeeze Earnings
Turning Point Brands (TPB) stock rose despite a decline in net income, driven by strong growth in nicotine pouch sales which now account for nearly half of total revenue. While the Modern Oral segment shows powerful top-line growth, increased marketing and regulatory spending compressed adjusted EBITDA margins, leading to a sharp drop in net income and EPS. Investors face a trade-off between the company's growth engine and its softened earnings forecasts and margins.
Analysts’ Top Consumer Goods Picks: Turning Point Brands (TPB), Ingredion (INGR)
Analysts are showing bullish sentiments toward two consumer goods companies, Turning Point Brands (TPB) and Ingredion (INGR). Roth MKM analyst Nick Anderson reiterated a Buy rating for TPB with a $125.00 price target, while Benchmark Co.'s Ben Klieve assigned a Buy rating to Ingredion with a $130.00 price target. The article highlights the average price targets and analyst consensus for both stocks, suggesting potential upsides.
Can Turning Point Brands Defend a "Dr. Pepper"‑Size Share After the FDA's Nicotine Pouch Decision?
Turning Point Brands (NYSE: TPB) heavily relies on its Fre and ALP nicotine pouch lines for growth, with over 40% of its sales coming from this fast-growing segment. Upcoming earnings reports will be crucial to determine if the company can maintain its niche market share as larger tobacco companies enter the nicotine pouch market. The article also mentions Motley Fool's Stock Advisor did not recommend Turning Point Brands among its top 10 stocks.
Turning Point Brands (TPB) Stock Rises As Nicotine Pouches Squeeze Earnings
Turning Point Brands (TPB) saw its stock rise by 2.6% despite a sharp drop in net income, primarily due to strong growth in its nicotine pouch segment (Modern Oral) which now accounts for nearly half of total net sales. While revenue is up, adjusted EBITDA and EPS fell as the company invested heavily in marketing and regulatory efforts for Modern Oral products. This creates a tension for investors, balancing significant top-line growth potential with compressed margins and the need for further investment, including a recent equity raise to fund the Modern Oral expansion.
Turning Point Brands (TPB) Stock Rises As Nicotine Pouches Squeeze Earnings
Turning Point Brands (TPB) stock rose after its Q2 2026 earnings report, driven by a significant increase in Modern Oral (nicotine pouch) revenue, which now accounts for nearly half of total net sales. Despite this top-line growth, adjusted EBITDA and net income fell sharply due to increased spending on marketing, sales, and regulatory work. Investors are now weighing the company's strong revenue growth in nicotine pouches against its compressed margins and earnings, raising questions about its 35.9x P/E valuation.
Turning Point Brands Q2 2026 earnings: Modern Oral growth lifts sales as spending weighs on profit
Turning Point Brands (TPB) reported a 22.6% increase in Q2 2026 net sales to $142.9 million, primarily driven by its Modern Oral segment. However, significant investments in sales, marketing, and freight costs led to a 50.0% drop in adjusted EBITDA to $15.2 million and a substantial decline in diluted EPS to $0.18. The company raised its full-year Modern Oral sales guidance but profitability remains a concern due to increased spending and shifting product mix impacting margins.
Sei Investments Co. Purchases 21,805 Shares of Turning Point Brands, Inc. $TPB
Sei Investments Co. significantly increased its stake in Turning Point Brands, Inc. (NYSE:TPB) by 46.5%, acquiring an additional 21,805 shares to bring its total holdings to 68,676 shares valued at $5.96 million. This move is part of broader institutional investor activity, with institutional investors owning 96.12% of the company's stock. Turning Point Brands recently reported strong quarterly earnings, beating analyst estimates with an EPS of $0.76 and a 16.8% revenue increase, and maintains a "Moderate Buy" consensus rating from analysts.
Turning Point Brands : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
Turning Point Brands (TPB) has released its Quarterly Report for the quarter ending June 30, 2026, detailing financial results and operational highlights. The company experienced a 22.6% increase in consolidated net sales to $142.96 million, primarily driven by growth in its Stoker's products segment, despite a decrease in the Zig-Zag products segment. Net income attributable to Turning Point Brands, Inc. decreased significantly to $3.598 million for the quarter, compared to $14.48 million in the prior year, influenced by increased selling, general, and administrative expenses, partially offset by tariff refunds.
Turning Point Brands Announces Second Quarter 2026 Results
Turning Point Brands (NYSE: TPB) announced its second-quarter 2026 financial results, highlighted by a significant increase in Modern Oral Gross Revenue of 149% to $87.0 million and Net Sales of 128% to $68.4 million, now accounting for 48% of total company net sales. The company raised its full-year 2026 Modern Oral Gross and Net Sales guidance, despite a decrease in consolidated net income and Adjusted EBITDA due to strategic sales and marketing investments. The Stoker's segment saw strong growth driven by Modern Oral, while the Zig-Zag segment experienced a slight decrease in net sales.
Turning Point’s Modern Oral Boosts Q2 Growth
Turning Point Brands reported a significant increase in second-quarter net sales, up 22.6% to $142.9 million, primarily driven by strong performance in its modern oral nicotine business. Modern oral gross revenue surged 149% to $87 million, leading the company to raise its full-year modern oral sales guidance. Despite these gains, net income and adjusted EBITDA declined due to increased sales and marketing investments.
Earnings call transcript: Turning Point Brands tops revenue in Q2 2026
Turning Point Brands reported mixed Q2 2026 results, with revenue of $142.96 million exceeding forecasts, driven by strong growth in its Modern Oral business, though adjusted EPS missed estimates at $0.23 due to aggressive growth spending. The company raised its full-year Modern Oral sales guidance but maintained its EBITDA guidance, reflecting a strategy to invest in long-term brand building and market share expansion. The stock saw a slight premarket dip but analysts see significant upside potential.
Turning Point Brands Reports Q2 2026 Results: Full Earnings Call Transcript
Turning Point Brands reported strong Q2 2026 results, with Modern Oral gross and net sales increasing by 149% and 128% year-over-year, respectively, now comprising 48% of total revenue. The company is strategically investing in retail distribution expansion, a larger sales force, and future U.S. manufacturing to drive long-term growth and market share in the evolving nicotine consumption category. Despite a 50% decrease in adjusted EBITDA due to significant sales and marketing investments, the full-year 2026 sales guidance for Modern Oral was raised, and overall EBITDA guidance was maintained, reflecting confidence in their strategic initiatives.
Turning Point Brands (TPB) Lags Q2 Earnings Estimates
Turning Point Brands (TPB) reported Q2 earnings of $0.23 per share, missing the Zacks Consensus Estimate of $0.24 per share, despite exceeding revenue expectations with $142.96 million. The company's stock has underperformed the S&P 500 this year, leading to a Zacks Rank #4 (Sell) due to unfavorable estimate revisions. Investors are now looking to management's commentary and future earnings outlook for insights into the stock's potential movement.
Earnings Flash (TPB) Turning Point Brands, Inc. Reports Q2 Revenue $143.0M, vs. FactSet Est of $129.6M
Turning Point Brands, Inc. (TPB) announced its Q2 2026 revenue reached $143.0 million, surpassing FactSet's estimate of $129.6 million. The company reported adjusted EPS of $0.23 per share, slightly below the FactSet estimate of $0.28. Turning Point Brands continues to offer Zig-Zag and Stoker's branded consumer products, expanding its reach into new markets.
Earnings Flash (TPB) Turning Point Brands, Inc. Posts Q2 Adjusted EPS $0.23 per Share, vs. FactSet Est of $0.28
Turning Point Brands, Inc. (TPB) reported its Q2 adjusted EPS at $0.23 per share, falling short of the FactSet estimate of $0.28. This financial update indicates a miss on analyst expectations for the quarter. The company also reported Q2 revenue of $143.0M, surpassing the FactSet estimate of $129.6M.
Turning Point Brands Raises 2026 Guidance After 128% Sales Gain
Turning Point Brands (NYSE: TPB) announced strong financial results for Q2 2026, driven by a 128% increase in Modern Oral net sales to $68.4 million. The company raised its full-year 2026 guidance for Modern Oral gross and net sales, now projected at $330-$350 million and $260-$270 million respectively, and anticipates Adjusted EBITDA of $70-$90 million. These results reflect successful investments in retail distribution and brand development, positioning TPB to capitalize on the growing shift towards modern oral nicotine consumption.
SWP Investment Management LLC Acquires New Holdings in Turning Point Brands, Inc. $TPB
SWP Investment Management LLC has acquired a new stake of 25,630 shares in Turning Point Brands, Inc. (NYSE:TPB), valued at approximately $2.17 million. Institutional investors collectively own 96.12% of the company, and analysts generally rate the stock as a "Moderate Buy" with an average price target of $113.50. Turning Point Brands recently surpassed quarterly earnings and revenue estimates and declared a quarterly dividend of $0.08 per share.
TPB|Turning Point Brands Inc|Price:80.558|Chg%:+5.948
Turning Point Brands Inc (TPB) has strong fundamentals and high growth potential, with its valuation considered fairly valued. Analysts have rated it a "Buy" with a target price of $123.00, and institutional ownership is very high. Despite recent weak stock market performance, the company shows stable dividends, high profit growth, and steady revenue growth over the past three years.
Militia Capital Management LLC Acquires New Position in Turning Point Brands, Inc. $TPB
Militia Capital Management LLC initiated a new position in Turning Point Brands (NYSE:TPB) by acquiring 40,000 shares valued at approximately $3.47 million in the first quarter. This comes as Turning Point Brands exceeded first-quarter expectations with strong earnings and revenue growth, and institutional investors now own 96.12% of the company's stock. Analysts maintain a "Moderate Buy" rating for TPB with a consensus target price of $113.50.
Turning Point Brands faces earnings test as estimates tumble
Turning Point Brands Inc. is set to report its second-quarter results, with analysts expecting a significant decline in EPS despite revenue growth, largely due to sharp profit estimate cuts. Investors are focused on the company's transformation into a nicotine-pouch powerhouse, particularly the performance of its ALP joint venture and the impact on margins. The article highlights the premium valuation of the stock, indicating high expectations for its pouch segment's continued execution.
(TPB) Price Dynamics and Execution-Aware Positioning
This article analyzes Turning Point Brands Inc. (NYSE: TPB) focusing on its price dynamics and execution-aware positioning. It identifies a strong near-term sentiment potentially challenging mid and long-term weakness, alongside an exceptional risk-reward setup. The piece also outlines institutional trading strategies, including position, momentum breakout, and risk hedging, based on AI-generated signals for various time horizons.
Turning Point Brands (TPB) Keeps Its Dividend As Valuation Debate Comes Into Focus
Turning Point Brands (TPB) has declared a regular quarterly dividend of $0.08 per share, amidst a recent downturn in its stock price despite strong long-term performance. A valuation debate is underway, with one narrative suggesting TPB is 42.6% undervalued at a fair value of $130 due to its premium brand growth and margin assumptions, while another discounted cash flow model indicates it is overvalued at $44.97. Investors are encouraged to review both perspectives and associated risks.
Turning Point Brands, Inc. $TPB is Prospect Capital Advisors LLC's 9th Largest Position
Prospect Capital Advisors LLC has made Turning Point Brands, Inc. (NYSE:TPB) its ninth-largest position, despite reducing its stake by 12.7% in the first quarter. Institutional investors collectively own 96.12% of the company's stock, and analysts maintain a "Moderate Buy" consensus rating with a $113.50 average price target. Turning Point Brands recently reported strong quarterly results, beating EPS and revenue estimates, and declared a quarterly dividend of $0.08.
Turning Point Brands (NYSE:TPB) Downgraded to Strong Sell Rating by Wall Street Zen
Wall Street Zen downgraded Turning Point Brands (NYSE:TPB) to a "Strong Sell" rating, despite MarketBeat's overall analyst consensus remaining a "Moderate Buy." The company's shares opened at $74.90, significantly below its 52-week high, although it recently exceeded quarterly earnings and revenue expectations. Institutional investors hold a substantial 96.12% of the stock.
Access Investment Management LLC Sells 41,255 Shares of Turning Point Brands, Inc. $TPB
Access Investment Management LLC reduced its stake in Turning Point Brands (NYSE:TPB) by 56.1%, selling 41,255 shares and retaining 32,335 shares. Insiders, including Chief Accounting Officer Brian Wigginton, also sold shares, though institutional investors collectively own 96.12% of the company. Despite these sales, Turning Point Brands exceeded quarterly earnings and revenue estimates, and analysts maintain a "Moderate Buy" rating with a target price of $113.50.
Norris Financial Group LLC Makes New $4.15 Million Investment in Turning Point Brands, Inc. $TPB
Norris Financial Group LLC has made a new investment of $4.15 million in Turning Point Brands, Inc. (NYSE:TPB), acquiring 47,824 shares. This move highlights institutional confidence in the company, which is also supported by a "Moderate Buy" analyst consensus and strong quarterly earnings, beating expectations with $0.76 EPS and $124.28 million in revenue. The company also declared a $0.08 quarterly dividend.
First Trust entities (NYSE: TPB) disclose 5.42% beneficial stake in Turning Point Brands
First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have collectively reported a beneficial ownership of 1,049,564 shares, or 5.42%, in Turning Point Brands, Inc. This stake is primarily held through unit investment trusts and other managed accounts, with shared voting and dispositive powers. The reporting entities, however, disclaim beneficial ownership of these shares, which are voted by the trustee in a pro-rata manner.
BTIG Initiates Turning Point Brands(TPB.US) With Buy Rating, Announces Target Price $103
BTIG has initiated coverage on Turning Point Brands (TPB.US) with a Buy rating. The firm has set a price target of $103 for the company's stock.
Turning Point Brands, Inc. $TPB Shares Purchased by Riposte Capital LLC
Riposte Capital LLC significantly increased its stake in Turning Point Brands (NYSE:TPB) during the first quarter by 50%, acquiring an additional 50,000 shares. This move brings their total holdings to 150,000 shares, valued at approximately $13 million. Turning Point Brands has received a "Moderate Buy" consensus rating from analysts, a 0.4% dividend yield, and recently exceeded quarterly earnings and revenue expectations.
Press Release: Turning Point Brands Declares Common Stock Dividend
Turning Point Brands (TPB) announced its quarterly common stock dividend of $0.07 per share. The dividend is payable on August 15, 2024, to shareholders of record as of July 31, 2024.
Turning Point Brands declares $0.08 quarterly dividend By Investing.com
Turning Point Brands, Inc. (NYSE:TPB) announced a quarterly dividend of $0.08 per common share. The dividend is payable on October 9, 2026, to shareholders of record as of September 18, 2026. The company manufactures, markets, and distributes branded consumer products, including alternative smoking accessories and consumables.
